tiprankstipranks
Trending News
More News >
Boundless Bio Inc. (BOLD)
NASDAQ:BOLD
US Market

Boundless Bio Inc. (BOLD) Financial Statements

Compare
40 Followers

Boundless Bio Inc. Financial Overview

Boundless Bio Inc.'s market cap is currently $26.22M. The company's EPS TTM is $-0.58; its P/E ratio is -0.46; Boundless Bio Inc. is scheduled to report earnings on March 9, 2026, and the estimated EPS forecast is $-0.58. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total Revenue$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit$ -1.25M$ -1.09M$ 0.00$ 0.00$ 0.00
Operating Income$ -63.55M$ -73.27M$ -54.80M$ -46.47M$ -25.30M
EBITDA$ -62.30M$ -64.28M$ -53.84M$ -45.53M$ -24.62M
Net Income$ -58.20M$ -65.36M$ -49.43M$ -45.90M$ -25.21M
Balance Sheet
Cash & Short-Term Investments$ 107.58M$ 152.11M$ 120.75M$ 66.72M$ 73.03M
Total Assets$ 157.06M$ 206.41M$ 129.89M$ 76.83M$ 113.72M
Total Debt$ 49.03M$ 47.63M$ 2.19M$ 5.18M$ 377.00K
Net Debt$ 31.17M$ 21.05M$ -21.51M$ -5.77M$ -33.91M
Total Liabilities$ 58.41M$ 55.77M$ 256.98M$ 158.53M$ 151.91M
Stockholders' Equity$ 98.65M$ 150.64M$ -127.08M$ -81.70M$ -38.19M
Cash Flow
Free Cash Flow$ -47.21M$ -63.38M$ -47.49M$ -40.66M$ -25.28M
Operating Cash Flow$ -46.66M$ -60.84M$ -46.85M$ -39.60M$ -23.25M
Investing Cash Flow$ 37.80M$ -26.10M$ -38.26M$ 16.13M$ -59.28M
Financing Cash Flow$ 141.00K$ 89.82M$ 97.90M$ 126.00K$ 105.53M
Currency in USD

Boundless Bio Inc. Earnings and Revenue History

Boundless Bio Inc. Debt to Assets

Boundless Bio Inc. Cash Flow

Boundless Bio Inc. Forecast EPS vs Actual EPS